Movatterモバイル変換

[0]ホーム
URL:

Carreer et al., 1998 - Google Patents

Oxidant-scavenging activities of beta-lactam agents

Carreer et al., 1998

Document ID
18389481567352519088
Author
Carreer R
Deby-Dupont G
Deby C
Jadoul L
Mathy M
Publication year
Publication venue
European Journal of Clinical Microbiology and Infectious Diseases

External Links

Snippet

The relative antioxidant effect of ampicillin, ceftazidime, ceftriaxone, and cefuroxime on oxygenreactive species was examined in vitro using stimulated human polymorphonuclear neutrophils. There was no evidence that any of the β-lactam agents tested had an effect on …
Continue reading atlink.springer.com (other versions)

Classifications

The classifications are assigned by a computer and are not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

PublicationPublication DateTitle
US6423312B1 (en)Compositions including glycosaminoglycans degrading enzymes and use of same against surface protected bacteria
EP3040076B1 (en)A composition comprising a non-peptide antibiotic and cysteamine
EP2302031A1 (en)Compositions and methods for enzymatic detachment of bacterial and fungal biofilms
Barrett-Bee et al.The membrane destabilising action of the antibacterial agent chlorhexidine
Carreer et al.Oxidant-scavenging activities of beta-lactam agents
Sonstein et al.Effect of low concentrations of quinolone antibiotics on bacterial virulence mechanisms
Adinolfi et al.Enhanced phagocytosis, killing, and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MICs of imipenem
Umamageswari et al.Evaluation of antibacterial activity of zinc oxide nanoparticles against biofilm producing methicillin resistant Staphylococcus aureus (MRSA)
Maan et al.DP1, a multifaceted synthetic peptide: Mechanism of action, activity and clinical potential
Lindsay et al.Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections a randomized, double-blind trial
EP3641750A1 (en)Method for reducing lung infection
Murad et al.Antimicrobial effect of Tetraspanin CD9 Peptides on Pseudomonas aeruginosa.
Ras et al.Clindamycin, erythromycin, and roxithromycin inhibit the proinflammatory interactions of Pseudomonas aeruginosa pigments with human neutrophils in vitro
WO2004022048A1 (en)Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract
AllenNonclassical targets for antibacterial agents
Fietta et al.Inhibition of intracellular growth of Staphylococcus aureus by exposure of infected human monocytes to clarithromycin and azithromycin
WO2017212239A1 (en)Treatment of drug-resistant microbial infections
Gómez-Lus et al.Effect of polymorphonuclear neutrophils on serum bactericidal activity against Streptococcus pneumoniae after amoxicillin administration
Edelstein et al.In vitro activity of Ro 23-9424 against clinical isolates of Legionella species
Di Martino et al.Effects of antibiotics on adherence of Pseudomonas aeruginosa and Pseudomonas fluorescens to A549 pneumocyte cells
Donowitz et al.Azithromycin inhibition of intracellular Legionella micdadei
US20170348253A1 (en)Treatment of Drug-Resistant Microbial Infections
Ahmed et al.Effects of Silver Nanoparticles on Biofilms of Streptococcus Spps
Wihanto et al.Effects Of Ethanol-based Antiseptic Solutions Against Gram Negative Bacteria
PresslitzMode of action of a structurally novel beta-lactam
[8]ページ先頭
©2009-2025 Movatter.jp